Get the Stockscreener App
0.0674
2.04%
0.00135
After Hours:
.07
0.0026
+3.86%
Overview
News
Price History
Financials
Why BIOL Down?
Discussions
Forecast
Stock Split
Dividend History
Biolase Inc stock is traded at $0.0674, with a volume of 133.71K.
It is up +2.04% in the last 24 hours and down -54.77% over the past month.
See More
Previous Close:
$0.0661
Open:
$0.0677
24h Volume:
133.71K
Relative Volume:
29.21
Market Cap:
$N/A
Revenue:
$49.16M
Net Income/Loss:
$-20.63M
P/E Ratio:
-0.000254
EPS:
-264.93
Net Cash Flow:
$-15.40M
1W Performance:
+22.55%
1M Performance:
-54.77%
6M Performance:
-93.54%
1Y Performance:
-4.10%
1-Day Range:
$0.0612
$0.068
1-Week Range:
$0.0612
$0.0702
52-Week Range:
$0.053
$0.0702
Biolase Inc Stock (BIOL) Company Profile
Biolase Inc Stock (BIOL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | The Benchmark Company | Speculative Buy |
| Apr-25-17 | Initiated | Singular Research | Buy |
| May-13-14 | Downgrade | WallachBeth | Buy → Hold |
| Nov-12-13 | Reiterated | WallachBeth | Buy |
| Aug-08-13 | Reiterated | WallachBeth | Buy |
| Jun-17-13 | Initiated | WallachBeth | Buy |
| Mar-18-13 | Reiterated | Northland Capital | Outperform |
| Mar-07-13 | Reiterated | Northland Capital | Outperform |
| Sep-07-12 | Initiated | Northland Securities | Outperform |
View All
Biolase Inc Stock (BIOL) Latest News
Medical Dental Istruments Market Regional Analysis – AMD Lasers, Planmeca Group, Dentsply SironA, Biolase - Cauverynews
Related Content: Biolase Awarded Patent for Tooth-Whitening System | Sep 2007 - Photonics.com
Sonendo eyes Biolase assets By Investing.com - Investing.com Australia
Sonendo eyes Biolase assets - Investing.com India
Sonendo eyes Biolase assets - Investing.com
BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com - Defense World
Canada Dental Tools Market May See a Big Move | Midmark, Biolase, 3M - openPR
Social Media in the Medical Device Market 2024 Development Analysis – Biolase Inc, DexCom Inc, Medtronic Plc, Twitter – Cauverynews - Cauverynews
Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS Technologi - ForexTV.com
Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition Corp.; AERWINS Technologi - StockTitan
BIOLASE (NASDAQ:BIOL) Price Target Lowered to $2.00 at Ascendiant Capital Markets - Defense World
BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022 - BioSpace
United States Dental Equipment Market Forecast and Company - GlobeNewswire
United States Dental Equipment Market Forecast and Company Analysis 2024-2032 Featuring 3M, Straumann, Dentsply Sirona, ZimVie, Envista, Biolase, Young Innovations, Midmark, Takara Belmont, Ultradent - Yahoo Finance
StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL) - Defense World
Dental Surgical Equipment Market Growing Rapidly by 2031 - openPR
Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris Therapeutics, Alma Lasers, BIOLASE, BioLineRx, DermBiont, Novartis and Pulse Biosciences - GlobeNewswire
Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris - Daily Guardian Canada
BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com - Defense World
Biolase (FRA:BTH0) Book Value per Share : €-0.12 (As of Jun. 2024) - GuruFocus.com
Biolase (FRA:BTH0) Enterprise Value : €12.97 Mil (As of Aug. 19, 2024) - GuruFocus.com
Biolase (FRA:BTH0) Total Assets : €28.47 Mil (As of Jun. 2024) - GuruFocus.com
Biolase (FRA:BTH0) Inventory-to-Revenue : 0.96 (As of Jun. 2024) - GuruFocus.com
BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023 - GuruFocus.com
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Publ - GuruFocus.com
BIOLASE (NASDAQ:BIOL) Receives Speculative Buy Rating from Benchmark - Defense World
BIOLASE (NASDAQ:BIOL) Posts Earnings Results - Defense World
Dental Lasers Market May See a Big Move| Dentsply Sirona, BIOLASE, Fotona, Gigaalaser - openPR
Biolase: Q2 Earnings Snapshot - CTPost
BIOL Stock Earnings: Biolase Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Biolase: Q2 Earnings Snapshot - San Antonio Express-News
Biolase: Q2 Earnings Snapshot - The Bakersfield Californian
BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen - StockTitan
BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen - wallstreet:online
StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL) - Defense World
Dental Laser Market Huge Growth in Future Scope 2024-2031 | AMD - openPR
BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com - Defense World
Dental X-ray Market is anticipated to generate an estimated - openPR
BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com - Defense World
Dental Manufacturing Market to show Robust Growth in Upcoming Years by 2024-2031 Ivoclar Vivadent, Henry Schein, Straumann, Biolase Inc., Carestream Health – TIMC - TIMC
BIOLASE, Inc. (NASDAQ:BIOL) Sees Significant Drop in Short Interest - Defense World
BIOLASE delisted from Nasdaq Stock Market - Dental Tribune International
BIOLASE Wins Patent Infringement Case in Germany - Yahoo Eurosport UK
Biolase (OTCMKTS: BIOL) Revs Up After Strategic Partnership - All Finance Times
Wave Photonics Secures £4.5M Seed Round: Week in Brief: 6/21/24 | Business | Jun 2024 - Photonics.com
BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com - Defense World
Market Analysts see Biolase Inc [BIOL] gaining to $2. Time to buy? – The DBT News - The DBT News
Get in on Biolase Inc's (BIOL) buy-in window today! – Sete News - SETE News
Post-Trade Analysis: Biolase Inc (BIOL) Slides -13.19, Closing at 0.13 – DWinneX - The Dwinnex
BIOLASE RECEIVES SECOND TOP WORKPLACES 2022 AWARD - Quantisnow
BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM ... - Quantisnow
Biolase Inc Stock (BIOL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Cap:
|
Volume (24h):